Herbas VPB

Print
EN | LT
LT - ORAL SOLID DOSAGE FORMULATION OF 1,1-DIMETHYLETHYL [(1S)-1-{[(2S,4R)-4-(7-CHLORO-4METHOXYISOQUINOLIN-1-YLOXY)-2-({(1R,2S)-1-[(CYCLOPROPYLSULFONYL)CARBAMOYL]-2-ETHENYLCYCLOPROPYL}CARBAMOYL)PYRROLIDIN-1-YL]CARBONYL}-2,2-DIMETHYLPROPYL]CARBAMATE
EN - ORAL SOLID DOSAGE FORMULATION OF 1,1-DIMETHYLETHYL [(1S)-1-{[(2S,4R)-4-(7-CHLORO-4METHOXYISOQUINOLIN-1-YLOXY)-2-({(1R,2S)-1-[(CYCLOPROPYLSULFONYL)CARBAMOYL]-2-ETHENYLCYCLOPROPYL}CARBAMOYL)PYRROLIDIN-1-YL]CARBONYL}-2,2-DIMETHYLPROPYL]CARBAMATE

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 9/20
A61K 31/4709
A61P 31/14
European patent
(11) Number of the document 2846778
(13) Kind of document T
(96) European patent application number 13722251.9
Date of filing the European patent application 2013-05-03
(97) Date of publication of the European application 2015-03-18
(45) Date of publication and mention of the grant of the patent 2018-04-25
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/US2013/039378
Date 2013-05-03
PCT application publication
(87) Number WO 2013/169577
Date 2013-11-14
Priority applications
(30) Number Date Country code
201261643486 P 2012-05-07 US
Inventors
(72)
HAMEY, Rhye, US
PANDEY, Preetanshu, US
BINDRA, Dilbir S., US
VEMAVARAPU, Chandra, US
PERRONE, Robert Kevin, US
Grantee
(73) Bristol-Myers Squibb Holdings Ireland, Hinterbergstrasse 16, Steinhausen, CH
Title
(54) ORAL SOLID DOSAGE FORMULATION OF 1,1-DIMETHYLETHYL [(1S)-1-{[(2S,4R)-4-(7-CHLORO-4METHOXYISOQUINOLIN-1-YLOXY)-2-({(1R,2S)-1-[(CYCLOPROPYLSULFONYL)CARBAMOYL]-2-ETHENYLCYCLOPROPYL}CARBAMOYL)PYRROLIDIN-1-YL]CARBONYL}-2,2-DIMETHYLPROPYL]CARBAMATE
  ORAL SOLID DOSAGE FORMULATION OF 1,1-DIMETHYLETHYL [(1S)-1-{[(2S,4R)-4-(7-CHLORO-4METHOXYISOQUINOLIN-1-YLOXY)-2-({(1R,2S)-1-[(CYCLOPROPYLSULFONYL)CARBAMOYL]-2-ETHENYLCYCLOPROPYL}CARBAMOYL)PYRROLIDIN-1-YL]CARBONYL}-2,2-DIMETHYLPROPYL]CARBAMATE